NasdaqGM - Nasdaq Real Time Price USD
Kalaris Therapeutics, Inc. (KLRS)
6.75
-0.26
(-3.71%)
As of 12:20:00 PM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
-16,955
-14,132
-9,779
Financing Cash Flow
18,422
14,242
12,780
End Cash Position
1,913
3,169
3,059
Issuance of Capital Stock
8,333
6,742
8,475
Issuance of Debt
9,993
6,000
4,300
Free Cash Flow
-16,955
-14,132
-9,779
12/31/2022 - 7/30/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARMP Armata Pharmaceuticals, Inc.
1.3650
+3.41%
MNOV MediciNova, Inc.
1.4600
-2.01%
DNTH Dianthus Therapeutics, Inc.
21.64
+0.37%
AKESF Akeso, Inc.
12.90
+7.50%
IPHA Innate Pharma S.A.
1.9700
0.00%
UBX Unity Biotechnology, Inc.
0.9995
+1.37%
CELC Celcuity Inc.
10.92
-1.36%
SION Sionna Therapeutics, Inc.
12.65
-3.36%
AIMI AIM ImmunoTech Inc.
0.0560
+41.06%
SYRE Spyre Therapeutics, Inc.
14.47
+1.76%